Neolignans from plants in northeastern Brazil (Lauraceae) with activity against Trypanosoma cruzi

Experimental Parasitology

Volumn 124, Issue 3, 2010, Pages 319-324

  Cabral, M M O ^a   Barbosa Filho, J M ^b   Maia, G L A ^b   Chaves, M C O ^b   Braga, M V ^a   De Souza, W ^c   Soares, R O A ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Burchellin; Chemotherapy; Licarin A; Nectandra glabrescens; Neolignans; Ocotea cymbarum; Trypanosoma cruzi

Indexed keywords

BURCHELLIN; DNA; LICARIN A; NEOLIGNAN; UNCLASSIFIED DRUG;

ANTIPROTOZOAL ACTIVITY; ARTICLE; AUTOPHAGY; BRAZIL; CELL VIABILITY; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG ISOLATION; DRUG STRUCTURE; EPIMASTIGOTE; GOLGI COMPLEX; IC 50; MICROBIAL GROWTH; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOSOME; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALS; BENZOFURANS; BLOOD TRANSFUSION; BRAZIL; CELL SURVIVAL; CHAGAS DISEASE; HUMANS; INHIBITORY CONCENTRATION 50; LIGNANS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; PLANT EXTRACTS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI;

LAURACEAE; NECTANDRA; OCOTEA; TRYPANOSOMA CRUZI;

EID: 76349106893     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2009.11.007     Document Type: Article

References (55)

1. Araújo M.S., Martins-Filho O.A., Pereira M.E., Brener Z. A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease. Journal Antimicrobial Chemotherapy 2000, 45:819-824.
2. Barbosa-Filho J.M., Silva M.S., Yoshida M., Gottlieb O.R. Neolignans from. Phytochemistry 1989, 28:2209-2211.
3. Barbosa-Filho J.M., Yoshida M., Gottlieb O.R. Lignoids from and. Phytochemistry 1989, 28:1991.
4. 13C NMR spectra of some lignoids from Lauraceae. Magnetic Resonance in Chemistry 1998, 36:929-935.
5. Boechat N., Carvalho A.S., Fernandez-Ferreira E., Soares R.O., Souza A.S., Gibaldi D., Bozza M., Pinto A.C. Novel nitroimidazoles with trypanocidal and cell growth inhibition activities. Cytobios 2001, 105:83-90.
6. Braga M.V., Urbina J.A., De Souza W. Effects of squalene synthase inhibitors on the growth and ultrastructure of. International Journal of Antimicrobial Agents 2004, 24:72-78.
7. 24(25)-sterol methyl transferase on the ultrastructure of epimastigote of. Microscopy and Microanalysis 2005, 11:506-515.
8. Brener Z., Cancado J.R., Galvão L.M., Luz Z.M., Filardi L.S., Pereira M.E., Santos L.M., Cancado C.B. An experimental and clinical assay with ketoconazole in the treatment of Chagas' disease. Memórias Instituto Oswaldo Cruz 1993, 88:149-153.
9. Buechi G., Mak C.P. Biomimetic syntheses of the neolignans guaianine, burchellin, 2-epi, 3a-epiburchellin and futoenone. Journal of America Chemical Society 1977, 99:8073-8075.
10. Cabral M.M.O., Azambuja P., Gottlieb O.R., Garcia E.S. Neolignans inhibit infection of its triatomine insect vector,. Parasitology Research 1999, 85:184-187.
11. Cabral M.M.O., Azambuja P., Gottlieb O.R., Garcia E.S. Effects of some lignans and neolignans on the development and excretion of. Fitoterapia 2000, 71:1-9.
12. Cabral M.M.O., Kollien A.H., Kleffmann T., Azambuja P., Gottlieb O.R., Garcia E.S., Schaub G.A.: effects of the neolignan burchellin on in vivo and in vitro diuresis. Parasitology Research 2000, 86:710-716.
13. Cabral M.M.O., Azambuja P., Gottlieb O.R., Kleffmann T., Garcia E.S., Schaub G.A. Burchellin: effects on and on within this vector. Parasitology Research 2001, 87:730-735.
14. Castro-Faria-Neto H.C., Bozza P.T., Cruz H.N., Silva C.L.M., Violante F.A., Barbosa-Filho J.M., Thomas G., Martins M.A., Tibiriçá E.V., Noel F., Cordeiro R.S.B. Yanganbim: a new naturally-occurring platelet-activating factor receptor antagonist: Binding and in vitro functional studies. Planta Medica 1995, 61:101-105.
15. Castro-Faria-Neto H.C., Araújo C.V., Moreira S., Bozza P.T., Thomas G., Barbosa-Filho J.M., Cordeiro R.S.B., Tibiriça E. Yanganbim: a new naturally-occurring platelet activating factor receptor antagonist: in vivo pharmacological studies. Planta Medica 1995, 61:106-112.
16. Chagas C. Nova tripanossomíase humana. Estudos sobre a morfologia e o ciclo evolutivo do n. gen., n. sp., agente etiológico de nova entidade mórbida do homem. Memórias Instituto Oswaldo Cruz 1909, 1:159-218.
17. Chunge C.N., Gachihi G., Muigai R., Wasunna K., Rashid J.R., Chulay J.D., Anabwani G., Oster C.N., Bryceson A.D. Visceral leishmaniasis unresponsive to antimonial drugs. III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Transactions of the Royal Society of Tropical Medical Hygiene 1985, 79:715-718.
18. Croft S.L., Sundar S., Farilamb A.H. Drug resistance in leishmaniasis. Clinical Microbiology Review 2006, 19:111-126.
19. Docampo R., Moreno S.N.J., Turrens J.F., Katzin A.M., Gonzales-Cappa S.M., Stoppani A.O.M. Biochemical and ultrastructural alterations produced by miconazole and econazole in. Molecular and Biochemical Parasitology 1981, 3:169-180.
20. Filardi L.S., Brener Z. Susceptibility and natural resistance of strains to drugs used clinically in Chagas' disease. Transactions of the Royal Society of Tropical Medical Hygiene 1987, 81:755-759.
21. Filleur F., Pouget C., Allais D.P., Kaouadji M., Chulia A.J. Lignans and neolignans from Warb. Natural Products Letters 2002, 16:1-7.
22. Freymann D.M., Wenck M.A., Engel J.C., Feng J., Focia P.J., Eakin A.E., Craig S.P. Efficient identification of inhibitors targeting the closed active site conformation of the HPRT from. Chemistry Biology 2000, 7:957-968.
23. Garcia E.S., Azambuja P. Infection of triatomines with. Molecular Biology of Insect Disease Vectors: a Methods Manual 1997, 146-155. Chapman and Hall, London. J.M. Crampton, C.B. Beard, C. Louid (Eds.).
24. Gottlieb O.R. The rational search for natural neolignans. Memórias Instituto Oswaldo Cruz 1991, 86(Suppl. 1):25-29.
25. Gottlieb O.R., Yoshida M. Lignans. Natural Products of Woody Plants: Chemicals Extraneous to the Lignocellulosic Cell Wall 1989, 439-511. Springer-Verlag, Berlin. J.W. Rowe (Ed.).
26. Gottlieb O.R., Yoshida M. Lignans: chemical, biological and clinical proprieties. Chemistry and Pharmacology of Natural Products 1990, Cambridge University Press. D.C. Ayres, J.D. Loike (Eds.).
27. Haughan P.A., Chance M.L., Goad L.J. Effects of an azasterol inhibitor of 24-transmethylation on sterol biosynthesis and growth of promastigotes. Biochemical Journal 1995, 308:31-38.
28. Herbert J.M., Castro-Faria-Neto H.C., Barbosa-Filho J.M., Cordeiro R.S.B., Tibiriçá E. Pharmacological evidence for the putative existence of two different subtypes of PAF receptors on platelets and leukocytes, studies with yangambin. Journal of Lipids Mediators and Cell Signalling 1997, 17:1-14.
29. Higuchi M.L. Chagas' disease. Importance of the parasite in the pathogenesis of the cardiac chronic disease. Arquivos Brasileiros de Cardiologia 1995, 64:251-254.
30. Lazardi K., Urbina J.A., De Souza W. Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of. Antimicrobial Agents and Chemotherapy 1990, 34:2097-2105.
31. Lazardi K., Urbina J.A., De Souza W. Ultrastructural alterations induced by ICI 195, 739, a bis-triazole with strong antiproliferative action against. Antimicrobial Agents and Chemotherapy 1991, 35:736-740.
32. Lopes N.P., Albuquerque S., Kato M.J., Yoshida M. Flavonoids and lignans from twigs and there in vitro activity against. Planta Medica 1998, 64:667-669.
33. Maldonado R.A., Molina J., Payares G., Urbina J.A. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease. Antimicrobial Agents and Chemotherapy 1993, 37:1353-1359.
34. Martin M.B., Grimley J.S., Lewis J.C., Heath H.T., Bailey B.N., Kendrick H., Yardley V., Caldera A., Lira R., Urbina J.A., Moreno S.N., Docampo R., Croft S.L., Oldfield E. Bisphosphonates inhibit the growth of , , and: a potential route to chemotherapy. Journal of Medicinal Chemistry 2001, 44:909-916.
35. Martins R.C.C., Lago J.H.G., Albuquerque S., Kato M.J. Trypanocidal tetrahydrofuran lignans from inflorescences of. Phytochemistry 2003, 64:667-670.
36. Monte Neto R.L., Barbosa-Filho J.M., Sousa L.M.A., Athayde-Filho P.F., Dias C.S., Oliveira M.R. Crude ethanolic extract, lignoid fraction and yangambin from (Lauraceae) show antileishmanial activity. Zeitschrist für Naturforsch 2007, 62c:348-352.
37. Morel C.M. Reaching maturity - 25 years of the TDR. Parasitology Today 2000, 16:522-528.
38. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 1983, 65:55-63.
39. Oliveira M.A., Souza W. An electron microscopic study of penetration by into midgut cells of. Journal of Invertebrate Pathology 2001, 77:22-26.
40. Petranyi G., Ryder N.S., Stutz A. Allylamine derivates: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase. Science 1984, 224:1239-1241.
41. Radloff P.D., Philipps J., Nkeyi M., Hutchinson D., Kremsner P.G. Atovaquone and proguanil for malaria. Lancet 1996, 347:1511-1514.
42. Rezende J.M. Manifestações clínicas da doença de chagas. Gastroenterologia Clinica 1993, 1729-1755. Guanabara Koogan, Rio de Janeiro, Brasil. R. Dani, L.P. Castro (Eds.).
43. 24(25)-sterol methyltransferase inhibitor, on promastigote and amastigote forms of. Antimicrobial Agents and Chemotherapy 2002, 46:487-499.
44. Ryder N.S. Mechanism of action and biochemical selectivity of allylamine antimycotic agents. Annals of the New York Academy of Sciences 1988, 544:208-220.
45. Santa-Rita R.M., Barbosa H.S., Urbina J.A., Castro S.L. Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis. Journal of Antimicrobial Chemotherapy 2005, 55:780-784.
46. Sauvain M., Kunesch N., Poisson J., Gantier J.C., Gayral P., Dedet J.P. Isolation of leishmanicidal triterpene and lignans from the Amazonian liana (Dilleniaceae). Phytotherapy Research 1996, 10:1-4.
47. Seifert K., Croft S.L. and interactions between miltefosine and other antileishmanial drugs. Antimicrobial Agents and Chemotherapy 2006, 50:73-79.
48. Serra M.F., Diaz B.L., Barreto E.O., Pereira A.P.B., Lima M.C.R., Barbosa-Filho J.M., Cordeiro R.S.B., Martins M.A., Silva P.M.R. Anti-allergic properties of natural PAF antagonist yangambin. Planta Medica 1997, 63:207-212.
49. Silva L.H.P., Nussenszweig V. Sobre uma cepa de virulenta para o. Folia Clinica et Biologica 1953, 20:191-207.
50. 24(25)-sterol methyltransferase inhibitors on: and studies. Chemotherapy (Tokyo) 1996, 42:294-307.
51. Vannier-Santos M.A., Urbina J.A., Martiny A., Neves A., De Souza W. Alteration induced by the antifungal compounds ketoconazole and terbinafine in. Journal of Eukaryotic Microbiology 1995, 42:337-346.
52. Vinhaes M.C., Schofield C.J. Trypanosomiasis control: surmounting diminishing returns. Trends in Parasitology 2003, 19:112-113.
53. 24(25)-sterol methyl transferase inhibitors and their combination with ketoconazole. International Journal of Antimicrobial Agents 1996, 7:235-240.
54. World Health Organization, 2006. Division of Control of Tropical Diseases. http://www.who.int/tdr/publications/publications/pdf.
55. Zhang H.J., Tamez P.A., Hoang V.D., Tan T.G., Hung N.V., Xuan L.T., Huong L.M., Cuong N.M., Thao D.T., Soejarto D.D., Fong H.H.S., Pezzuto J.M. Antimalarial compounds from. Journal of Natural Products 2001, 64:772-777.